First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study
Titel:
First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study
Auteur:
Dudnichenko, Oleksandr Penkov, Konstantin McKean, Meredith Mandalà, Mario Kukushkina, Mariia Panella, Timothy Csőszi, Tibor Gerletti, Paola Thakur, Mahgull Polli, Anna di Pietro, Alessandra Schadendorf, Dirk